US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Virtus LifeSci Biotech Products ETF

103.46

-0.0139-0.01%

Pre-market: 103.460.0003+0.00%07:00 EDT

Volume:8K

Turnover:858.59K

Market Cap:124.15M

PE:- -

High:104.51

Open:104.48

Low:103.45

Close:103.47

52wk High:110.05

52wk Low:68.05

Shares:1.20M

Float Shares:1.20M

Volume Ratio:0.98

T/O Rate:0.69%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Amneal receives FDA approval for additional iohexol strengths, presentations

Arbutus Biopharma Reshapes Strategy After Moderna Settlement

Virax Biolabs Boosts Liquidity, Secures Fosun Deal and Restores Nasdaq Compliance After Fiscal 2026 Report

IMF warns Bank of England against cutting interest rates

Vanda announces EMA positive opinion for orphan drug designation of Imsidolimab

Attovia Therapeutics, a Biopharmaceutical Firm Focused on Immune-Mediated Diseases, Files for U.S. IPO Seeking $100 Million

Regeneron’s dupilumab granted orphan drug designation

Celcuity announces FDA approval of Revtorpyk

Caris Life Sciences expands prostate cancer offering with PTEN IHC testing

Nexalis Therapeutics Options Expire Unexercised, Streamlining Capital Structure

Nexalis Therapeutics Issues Over 4.1 Million Unquoted Performance Rights

BioArctic’s Partner Eisai Wins FDA Nod for At-Home Leqembi Injection in Early Alzheimer’s

Lakefront Biotherapeutics Board Member Resigns After Sanofi R&D Appointment

Actinogen Medical Announces Employee Share Scheme Buy-Back

Island Pharmaceuticals Issues Unquoted Options Under Employee Incentive Scheme

Insilico Medicine Surges Over 7% in Morning Trading on New AI Drug Discovery Partnership with CMS

Genetic Technologies Faces ASX Deadlines Amid Long-Term Trading Suspension

ECB Officials Couldn't Overlook Energy Shock in June

Teva Pharmaceuticals Obtains Rights to Commercialize Polpharma's Biosimilar Candidate to Ocrevus

MT Newswires Live

ECB Officials Couldn't Look Through Energy Shock in June

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/stock/BBP/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BBP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBP\",,,,,undefined,":{"symbol":"BBP","market":"US","secType":"STK","nameCN":"Virtus LifeSci Biotech Products ETF","latestPrice":103.4597,"timestamp":1789156800000,"preClose":103.4736,"halted":0,"volume":8264,"hourTrading":{"tag":"盘前","latestPrice":103.46,"preClose":103.4597,"latestTime":"07:00 EDT","volume":7,"amount":724.2199999999999,"timestamp":1789383610133,"change":0.0003,"changeRate":0.000003,"amplitude":0},"delay":0,"changeRate":-0.00013433378175695717,"floatShares":1200004,"shares":1200004,"eps":0,"marketStatus":"Pre-Mkt","change":-0.0139,"latestTime":"09-14 08:06:23 EDT","open":104.48,"high":104.51,"low":103.45,"amount":858590.9244799999,"amplitude":0.010244,"askPrice":165.53,"askSize":200,"bidPrice":91.28,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789392600000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":103.4597,"sharesOutstanding":600004,"nav":103.362,"aum":124035301.07,"bidAskSpread":0.00263,"preHourTrading":{"tag":"盘前","latestPrice":103.46,"preClose":103.4597,"latestTime":"07:00 EDT","volume":7,"amount":724.2199999999999,"timestamp":1789383610133,"change":0.0003,"changeRate":0.000003,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":103.45,"preClose":103.4597,"latestTime":"19:30 EDT","volume":7,"amount":724.2785,"timestamp":1789169406685,"change":-0.0097,"changeRate":-0.000094,"amplitude":0},"volumeRatio":0.9846065698607303,"impliedVol":0.2114,"impliedVolPercentile":0.276},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBP\",,,,,undefined,":{"symbol":"BBP","floatShares":1200004,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.9846065698607303,"shares":1200004,"dividePrice":0,"high":104.51,"amplitude":0.010244,"preClose":103.4736,"low":103.45,"week52Low":68.046,"pbRate":"--","week52High":110.05,"institutionHeld":0,"latestPrice":103.4597,"committee":-0.333333,"eps":0,"divideRate":0,"volume":8264,"delay":0,"ttmEps":0,"open":104.48,"prevYearClose":79.9149,"prevWeekClose":103.4597,"prevMonthClose":106.46,"prevQuarterClose":96.2686,"fiveDayClose":108.8566,"twentyDayClose":101.0899,"sixtyDayClose":87.5667},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBP\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBP\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBP\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2652882192","title":"Amneal receives FDA approval for additional iohexol strengths, presentations","url":"https://stock-news.laohu8.com/highlight/detail?id=2652882192","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652882192?lang=en_us&edition=fundamental","pubTime":"2026-07-17 20:15","pubTimestamp":1784290509,"startTime":"0","endTime":"0","summary":"Amneal Pharmaceuticals (AMRX) announced that it has received FDA approval for additional strengths and vial presentations of iohexol injection, 350...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/amneal-receives-fda-approval-for-additional-iohexol-strengths-presentations-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/amneal-receives-fda-approval-for-additional-iohexol-strengths-presentations-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBB","BK4007","FRTY","SYNB","MRNX","BBP","TECB","GDOC","IDNA","IYH","BK4585","RSPH","LFSC","AMRX","BK4588","BMED","PINK","MRNY","PSCH","LABU","MEDI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652184401","title":"Arbutus Biopharma Reshapes Strategy After Moderna Settlement","url":"https://stock-news.laohu8.com/highlight/detail?id=2652184401","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652184401?lang=en_us&edition=fundamental","pubTime":"2026-07-17 17:37","pubTimestamp":1784281058,"startTime":"0","endTime":"0","summary":"Arbutus Biopharma ( ($ABUS) ) has provided an announcement. In March 2026, Arbutus, Genevant and Moderna entered a global patent litigation settlem...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/arbutus-biopharma-reshapes-strategy-after-moderna-settlement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/arbutus-biopharma-reshapes-strategy-after-moderna-settlement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBP","BK4139","ABUS","RND","MEDX","NXTI","USRD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652409835","title":"Virax Biolabs Boosts Liquidity, Secures Fosun Deal and Restores Nasdaq Compliance After Fiscal 2026 Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2652409835","media":"TIPRANKS","labels":["corporation","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652409835?lang=en_us&edition=fundamental","pubTime":"2026-07-17 16:48","pubTimestamp":1784278109,"startTime":"0","endTime":"0","summary":"Virax Biolabs Group Ltd. Class A ( ($VRAX) ) has issued an announcement. Virax Biolabs Group Limited, a Nasdaq-listed biotechnology company focused...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/virax-biolabs-boosts-liquidity-secures-fosun-deal-and-restores-nasdaq-compliance-after-fiscal-2026-report?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/virax-biolabs-boosts-liquidity-secures-fosun-deal-and-restores-nasdaq-compliance-after-fiscal-2026-report?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JDOC","LCLG","AGNG","XT","FHLC","IBB","NQmain","BK4585","FWD","DARP","BBP","BK4588","RSPH","SYNB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652471130","title":"IMF warns Bank of England against cutting interest rates","url":"https://stock-news.laohu8.com/highlight/detail?id=2652471130","media":"cityam","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652471130?lang=en_us&edition=fundamental","pubTime":"2026-07-17 11:55","pubTimestamp":1784260500,"startTime":"0","endTime":"0","summary":"The IMF said rates should remain on hold because of \"heightened uncertainty\"  The Bank of England must keep interest rates on hold for as long as risks from the Iran war persist, the International Monetary Fund has said.In its annual temperature check of Britain’s economic outlook, the fund warned rate setters to keep monetary policy “sufficiently restrictive” to avoid sparking a painful bout of inflation that becomes hard to contain.Economists have been closely monitoring the UK economy for signs that elevated oil prices caused by the Middle East conflict have led to a cascade of price rises in the wider economy.Bank of England policymakers are especially concerned about the emergence of so-called second-round effects – when an initial price shock spreads through an economy, leading workers to bargain for more wages, which in turn also gives companies breathing room to raise price further.","market":"us","thumbnail":"https://www.cityam.com/wp-content/uploads/2026/07/IMF-boss-Kristalina-Georgieva-warned-the-Bank-of-England.jpg?w=824&h=463&crop=1","type":0,"news_type":0,"thumbnails":["https://www.cityam.com/wp-content/uploads/2026/07/IMF-boss-Kristalina-Georgieva-warned-the-Bank-of-England.jpg?w=824&h=463&crop=1"],"rights":{"source":"cityam_highlight","url":"https://www.cityam.com/imf-warns-bank-of-england-against-interest-rate/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.cityam.com/imf-warns-bank-of-england-against-interest-rate/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"cityam_highlight","symbols":["IMF","BBP","TSLG","TSLS","TSLZ","AVSD","CAOS","TSLI","BBEU","CLIX","KOMP","TSII","TSLQ","07366","BK4582","VAW","TSLL","TSLW","TESL","BK4585","09766","TSLT","TEST","07766","CGDV","ANEW","IJK","TSLP","TSLO","FXR","IDEV","TSDD","FLGB","FXL","09366","TSL","TSYY","TSLR","TLA","CRSH","BK4588","UCC","ISVL","PEVC","TSLY","DFUV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652422420","title":"Vanda announces EMA positive opinion for orphan drug designation of Imsidolimab","url":"https://stock-news.laohu8.com/highlight/detail?id=2652422420","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652422420?lang=en_us&edition=fundamental","pubTime":"2026-07-17 04:35","pubTimestamp":1784234123,"startTime":"0","endTime":"0","summary":"Vanda Pharmaceuticals (VNDA) announced that the Committee for Orphan Medicinal Products at the European Medicines Agency has adopted a positive opi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vanda-announces-ema-positive-opinion-for-orphan-drug-designation-of-imsidolimab-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vanda-announces-ema-positive-opinion-for-orphan-drug-designation-of-imsidolimab-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VNDA","EPV","EMA","BK4139","BK4081","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120952118","title":"Attovia Therapeutics, a Biopharmaceutical Firm Focused on Immune-Mediated Diseases, Files for U.S. IPO Seeking $100 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1120952118","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120952118?lang=en_us&edition=fundamental","pubTime":"2026-07-15 10:54","pubTimestamp":1784084075,"startTime":"0","endTime":"0","summary":"Clinical-stage biopharmaceutical company Attovia Therapeutics has filed for an initial public offering with the goal of raising up to $100 million.The firm plans to list on the Nasdaq exchange under...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNX","MRNY","IBBQ","IPOS","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651484502","title":"Regeneron’s dupilumab granted orphan drug designation","url":"https://stock-news.laohu8.com/highlight/detail?id=2651484502","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651484502?lang=en_us&edition=fundamental","pubTime":"2026-07-15 05:05","pubTimestamp":1784063112,"startTime":"0","endTime":"0","summary":"Regeneron’s (REGN) dupilumab was granted FDA orphan drug designation, according to a post on the agency’s website. Published first on TheFly – the ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/regenerons-dupilumab-granted-orphan-drug-designation-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/regenerons-dupilumab-granted-orphan-drug-designation-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0889565916.HKD","LU0823434740.USD","LABU","LU0320765992.SGD","REGN","BBH","IBBQ","LU0289739699.SGD","LU1917777945.USD","LU2023250504.SGD","BBP","LU0114720955.EUR","LU2237438978.USD","IBB","LU0882574055.USD","LU0109394709.USD","BK4139","LU2362541513.USD","LU1974910355.USD","LU2362541273.HKD","BK4585","BK4588","LU2089984988.USD","LU0823434583.USD","LU2468319806.SGD","LU2362540622.SGD","LU0053666078.USD","LU0058720904.USD","LU2106854487.HKD","LU0823416689.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651655484","title":"Celcuity announces FDA approval of Revtorpyk","url":"https://stock-news.laohu8.com/highlight/detail?id=2651655484","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651655484?lang=en_us&edition=fundamental","pubTime":"2026-07-15 04:55","pubTimestamp":1784062511,"startTime":"0","endTime":"0","summary":"Celcuity (CELC) announced that the U.S. Food and Drug Administration approved REVTORPYK for the treatment of patients with hormone receptor positiv...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/celcuity-announces-fda-approval-of-revtorpyk-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/celcuity-announces-fda-approval-of-revtorpyk-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IYH","BK4585","PSCH","CELC","IBB","FRTY","BK4588","BK4139","IDNA","PINK","LABU","LFSC","SYNB","BMED","TECB","MRNY","MEDI","BBP","RSPH","GDOC","MRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651105407","title":"Caris Life Sciences expands prostate cancer offering with PTEN IHC testing","url":"https://stock-news.laohu8.com/highlight/detail?id=2651105407","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651105407?lang=en_us&edition=fundamental","pubTime":"2026-07-14 20:35","pubTimestamp":1784032510,"startTime":"0","endTime":"0","summary":"Caris Life Sciences (CAI) will offer in-house PTEN immunohistochemistry, or IHC, testing following the recent FDA approval of a biomarker-guided th...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/caris-life-sciences-expands-prostate-cancer-offering-with-pten-ihc-testing-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/caris-life-sciences-expands-prostate-cancer-offering-with-pten-ihc-testing-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MRNY","CAI","LABU","LFSC","PSCH","PTEN","BK4588","SYNB","BK4162","RSPH","TECB","FRTY","IBB","IYH","BMED","IHC","BBP","BK4585","MRNX","PINK","BK4092","IDNA","BK4139","MEDI","GDOC","BK4104"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651612476","title":"Nexalis Therapeutics Options Expire Unexercised, Streamlining Capital Structure","url":"https://stock-news.laohu8.com/highlight/detail?id=2651612476","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651612476?lang=en_us&edition=fundamental","pubTime":"2026-07-14 13:27","pubTimestamp":1784006857,"startTime":"0","endTime":"0","summary":"InhaleRx Limited ( ($AU:NX1) ) just unveiled an announcement. Nexalis Therapeutics Ltd, an ASX-listed biotechnology company trading under the ticke...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nexalis-therapeutics-options-expire-unexercised-streamlining-capital-structure?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nexalis-therapeutics-options-expire-unexercised-streamlining-capital-structure?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DARP","AGNG","BK4539","FWD","BK4139","FHLC","RSPH","XT","BK4585","BK4588","IBB","BBP","SYNB","BK4007","JDOC","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651247371","title":"Nexalis Therapeutics Issues Over 4.1 Million Unquoted Performance Rights","url":"https://stock-news.laohu8.com/highlight/detail?id=2651247371","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651247371?lang=en_us&edition=fundamental","pubTime":"2026-07-14 13:27","pubTimestamp":1784006835,"startTime":"0","endTime":"0","summary":"InhaleRx Limited ( ($AU:NX1) ) just unveiled an update. Nexalis Therapeutics Ltd is an Australian-listed biotechnology company focused on developin...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nexalis-therapeutics-issues-over-4-1-million-unquoted-performance-rights?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nexalis-therapeutics-issues-over-4-1-million-unquoted-performance-rights?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BBP","BK4585","BK4007","AGNG","IBB","SYNB","FHLC","BK4139","DARP","RSPH","JDOC","BK4539","FWD","XT","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651422771","title":"BioArctic’s Partner Eisai Wins FDA Nod for At-Home Leqembi Injection in Early Alzheimer’s","url":"https://stock-news.laohu8.com/highlight/detail?id=2651422771","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651422771?lang=en_us&edition=fundamental","pubTime":"2026-07-14 06:08","pubTimestamp":1783980525,"startTime":"0","endTime":"0","summary":"BioArctic AB Class B ( ($SE:BIOA.B) ) has shared an update. BioArctic’s partner Eisai has secured U.S. FDA approval for Leqembi Iqlik, a once-weekl...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bioarctics-partner-eisai-wins-fda-nod-for-at-home-leqembi-injection-in-early-alzheimers?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bioarctics-partner-eisai-wins-fda-nod-for-at-home-leqembi-injection-in-early-alzheimers?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0251143029.SGD","HBCP","IBB","LU2065171402.SGD","FRTY","SYNB","LU0516423091.SGD","MRNX","SG9999002414.USD","SG9999014492.USD","BBP","SG9999002620.SGD","TECB","LU1861220207.SGD","GDOC","IDNA","IYH","SE","LU2065170008.USD","LU2125910849.SGD","BK4585","FDNI","IE0031814969.USD","LU0499858438.USD","LU0589944569.HKD","BK4535","BK4554","LU0532188223.SGD","RSPH","LFSC","SG9999002406.SGD","LU0441851309.USD","BK4503","LU0516422366.SGD","LU0823039010.USD","BK4211","SG9999014484.SGD","BK4588","BMED","LU2360107671.USD","PINK","LU2152927971.USD","LU0516423174.USD","SG9999002679.SGD","BK4220","MRNY","PSCH","SG9999013478.USD","LABU","MEDI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651144496","title":"Lakefront Biotherapeutics Board Member Resigns After Sanofi R&D Appointment","url":"https://stock-news.laohu8.com/highlight/detail?id=2651144496","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651144496?lang=en_us&edition=fundamental","pubTime":"2026-07-14 04:57","pubTimestamp":1783976270,"startTime":"0","endTime":"0","summary":"Lakefront Biotherapeutics ( ($LKFT) ) has provided an update. Lakefront Biotherapeutics, a Belgium-based biotechnology company listed on Euronext a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lakefront-biotherapeutics-board-member-resigns-after-sanofi-rd-appointment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lakefront-biotherapeutics-board-member-resigns-after-sanofi-rd-appointment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DARP","RSPH","BK4007","JDOC","SNYNF","BK4585","SYNB","FWD","IBB","FHLC","XT","BBP","BK4588","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651019180","title":"Actinogen Medical Announces Employee Share Scheme Buy-Back","url":"https://stock-news.laohu8.com/highlight/detail?id=2651019180","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651019180?lang=en_us&edition=fundamental","pubTime":"2026-07-13 15:38","pubTimestamp":1783928315,"startTime":"0","endTime":"0","summary":"Actinogen Medical ( ($AU:ACW) ) has provided an announcement. Actinogen Medical Ltd., an ASX-listed biotechnology company trading under the ticker ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/actinogen-medical-announces-employee-share-scheme-buy-back-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/actinogen-medical-announces-employee-share-scheme-buy-back-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AGNG","JDOC","SYNB","BBP","FWD","XT","IBB","DARP","BK4585","BK4588","FHLC","RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651196208","title":"Island Pharmaceuticals Issues Unquoted Options Under Employee Incentive Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=2651196208","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651196208?lang=en_us&edition=fundamental","pubTime":"2026-07-13 14:33","pubTimestamp":1783924409,"startTime":"0","endTime":"0","summary":"Island Pharmaceuticals Ltd ( ($AU:ILA) ) has provided an announcement. Island Pharmaceuticals Ltd is an Australian-listed biotechnology company foc...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/island-pharmaceuticals-issues-unquoted-options-under-employee-incentive-scheme?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/island-pharmaceuticals-issues-unquoted-options-under-employee-incentive-scheme?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBP","BK4585","FWD","BK4588","RSPH","AGNG","FHLC","DARP","JDOC","XT","IBB","SYNB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156997423","title":"Insilico Medicine Surges Over 7% in Morning Trading on New AI Drug Discovery Partnership with CMS","url":"https://stock-news.laohu8.com/highlight/detail?id=1156997423","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156997423?lang=en_us&edition=fundamental","pubTime":"2026-07-13 10:10","pubTimestamp":1783908642,"startTime":"0","endTime":"0","summary":"Insilico Medicine (03696) shares rose more than 7% in early trading. At the time of writing, the stock is up 6.21% to HK$45.48, with a turnover of HK$332 million. On July 13th, according to a post on...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00867","CHAT","SG9999015978.USD","QTOC","IE00BMCWC346.EUR","LU2488822045.USD","SG9999015952.SGD","SG9999015986.USD","BK1593","SG9999004220.SGD","AGIX","IE00BVYPNQ40.USD","GDOC","LFSC","WRND","GSKH","BK1191","BBP","BK4585","IE00BVYPNP33.GBP","SBIO","IBB","ARTY","AIPO","IE00BGHQDM52.EUR","PBE","SG9999015945.SGD","IE00BYV24P56.USD","VTHR","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650074239","title":"Genetic Technologies Faces ASX Deadlines Amid Long-Term Trading Suspension","url":"https://stock-news.laohu8.com/highlight/detail?id=2650074239","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650074239?lang=en_us&edition=fundamental","pubTime":"2026-07-10 14:52","pubTimestamp":1783666376,"startTime":"0","endTime":"0","summary":"Genetic Technologies ( ($AU:GTG) ) has shared an update. Genetic Technologies Limited, a biotechnology company specializing in genetic testing and ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/genetic-technologies-faces-asx-deadlines-amid-long-term-trading-suspension?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/genetic-technologies-faces-asx-deadlines-amid-long-term-trading-suspension?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","AGNG","BBP","WDNA","BK4585","RSPH","XT","HELX","FHLC","FWD","SYNB","JDOC","DARP","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650927633","title":"ECB Officials Couldn't Overlook Energy Shock in June","url":"https://stock-news.laohu8.com/highlight/detail?id=2650927633","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650927633?lang=en_us&edition=fundamental","pubTime":"2026-07-09 21:41","pubTimestamp":1783604460,"startTime":"0","endTime":"0","summary":"The European Central Bank said it was unable to overlook the energy shock at its meeting in June, when higher energy prices were expected to push inflation above its 2% target over the medium term.The","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IJK","MDLV","MODL","TXUE","MAPP","ADPV","BBP","IMOM","EQRR","AVSD","FXD","EES","AVDV","CLIX","DFUV","FXL","AVIE","HGER","BAMA","BGH","GSG","ILCV","CMCI","FXR","BKCI","CAOS","KOMP","UCC","DIVZ","IUS","HIDV","IMCG","CGDV","LCG","VAW","CDC","BKDV","DECU","PRVS","BSR","PEVC","ARP","CGUI","CGUS","ANEW","CMDT","FT","IDEV","FLV","LGH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650593922","title":"Teva Pharmaceuticals Obtains Rights to Commercialize Polpharma's Biosimilar Candidate to Ocrevus","url":"https://stock-news.laohu8.com/highlight/detail?id=2650593922","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650593922?lang=en_us&edition=fundamental","pubTime":"2026-07-09 21:09","pubTimestamp":1783602548,"startTime":"0","endTime":"0","summary":"Teva Pharmaceutical Industries'  Teva Pharmaceuticals International subsidiary and Polpharma Biologics said Thursday they have signed a global licensing agreement that gives Teva exclusive rights to commercialize Polpharma's proposed biosimilar to multiple sclerosis drug Ocrevus.The licensing agreement covers both the intravenous and subcutaneous formulations of Polpharma's biosimilar candidate, the companies said.Under the agreement, Polpharma Biologics will be responsible for the development and manufacturing of the biosimilar candidate, while Teva will be tasked with regulatory submissions and subsequent commercialization in the US, Europe, Brazil, Canada, Australia, New Zealand, Israel, and Turkey, according to a statement.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4566","BK4007","TEVA","BK4559","BK4588","BK4596","LU2324357040.USD","LU1983299246.USD","BK4584","BK4585","BBP","BK4557"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650924226","title":"ECB Officials Couldn't Look Through Energy Shock in June","url":"https://stock-news.laohu8.com/highlight/detail?id=2650924226","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650924226?lang=en_us&edition=fundamental","pubTime":"2026-07-09 20:55","pubTimestamp":1783601700,"startTime":"0","endTime":"0","summary":"The European Central Bank said it was unable to overlook the energy shock at its meeting in June, when higher energy prices were expected to push inflation above its 2% target over the medium term.The","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TSLS","TXUE","IMOM","09366","ANEW","TSYY","AVDV","07366","TESL","TSLQ","FXR","CMDT","TSL","TSLT","KOMP","TSDD","TSLP","IJK","TSLW","CAOS","VAW","TSLZ","IUS","TSLG","CGDV","TSLL","DFUV","HGER","BGH","GSG","TEST","BKCI","EQRR","CLIX","TSLR","CMCI","TSII","AVIE","TSLO","TSLY","TSLI","CRSH","IDEV","07766","BBP","PEVC","TLA","FXL","UCC","AVSD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":7,"totalSize":155,"code":"91000000","status":"200"}]}}